For instance, in BC, such analyses have distinguished TAM subpopulations like TREM2+ TAMs, characterized by the expression of TREM2 and SPP1, and FOLR2+ TAMs, identifiable by FOLR2 and CD206 markers. This evidence concerns the gene FOLR2 and breast cancer.